Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
4.000
+0.020 (0.50%)
Feb 9, 2026, 9:52 AM EST - Market open

UPC Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
17.8623.0232.3140.1447.98
Revenue Growth (YoY)
-22.44%-28.74%-19.52%-16.34%56.27%
Cost of Revenue
11.5616.9521.9918.2522.66
Gross Profit
6.36.0710.3221.8925.33
Selling, General & Admin
8.5511.069.3321.276.17
Research & Development
0.673.034.867.645.47
Other Operating Expenses
-00.1-0.1
Operating Expenses
9.2214.0914.2828.9111.74
Operating Income
-2.92-8.02-3.97-7.0213.59
Interest Expense
-0.29-0.3-0.19-0.2-0.15
Interest & Investment Income
0.060.030.030.040.29
Earnings From Equity Investments
0.070.030.030.040.03
Other Non Operating Income (Expenses)
-0.590.15-0.240.05-0.08
EBT Excluding Unusual Items
-3.67-8.12-4.33-7.0913.68
Gain (Loss) on Sale of Assets
-0-0-0-0-0
Pretax Income
-3.67-8.12-4.33-7.0913.68
Income Tax Expense
-0.612.250.822.36
Net Income
-3.67-8.73-6.58-7.9111.32
Net Income to Common
-3.67-8.73-6.58-7.9111.32
Net Income Growth
----49.77%
Shares Outstanding (Basic)
00---
Shares Outstanding (Diluted)
00---
Shares Change (YoY)
3174.93%----
EPS (Basic)
-8.06-626.96---
EPS (Diluted)
-8.06-626.96---
Free Cash Flow
-5.32-9.751.07-1.4-15.59
Free Cash Flow Per Share
-11.67-700.61---
Gross Margin
35.28%26.37%31.93%54.53%52.78%
Operating Margin
-16.33%-34.83%-12.28%-17.49%28.32%
Profit Margin
-20.56%-37.90%-20.37%-19.70%23.59%
Free Cash Flow Margin
-29.78%-42.36%3.32%-3.48%-32.48%
EBITDA
-2.4-7.53-3.46-6.4914.04
EBITDA Margin
-13.43%-32.72%-10.70%-16.16%29.25%
D&A For EBITDA
0.520.490.510.530.45
EBIT
-2.92-8.02-3.97-7.0213.59
EBIT Margin
-16.33%-34.83%-12.28%-17.49%28.32%
Effective Tax Rate
----17.24%
Advertising Expenses
2.575.274.76-1.33
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q